Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_assertion type Assertion NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_head.
- NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_assertion description "[We found that anisomycin treatment (10-15 nM) alone had no effect on the level of apoptosis, but a combination treatment of anisomycin and TRAIL significantly increased the level of apoptosis in human renal carcinoma (Caki, ACHN and A498), human glioma (U251MG), and human breast carcinoma (MDA-MB-361 and MCF7) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_provenance.
- NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_assertion evidence source_evidence_literature NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_provenance.
- NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_assertion SIO_000772 23261849 NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_provenance.
- NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_assertion wasDerivedFrom befree-20150227 NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_provenance.
- NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_assertion wasGeneratedBy ECO_0000203 NP918086.RA5OT0NioSX4nFt4j8vatudIYjKOIrugb1QtCFFMgxEBU130_provenance.